BD Merges Biosciences & Diagnostics Business With Waters

Key Takeaways BDX completed the spin-off of Biosciences & Diagnostic and merged it with Waters.BD shareholders get 0.135 Waters shares per BD share; BD received $4B in cash proceeds.BDX will use $2B for buybacks and $2B for debt reduction to sharpen MedTech focus.Becton, Dickinson and Company (BDX) , popularly known as BD, recently announced that it has completed the previously disclosed spin-off of its Biosciences & Diagnostic business, followed by the merger of the separated entity with Waters Corporation ...